| Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer (NCT01869764) | Wake Forest University Health Sciences | 2013-11-01 |
| Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix (NCT02492503) | All India Institute of Medical Sciences | 2013-11-01 |
| Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer (NCT02072317) | Fudan University | 2013-11-01 |
| Tivozanib As Maintenance Therapy In GYN (NCT01972516) | Dana-Farber Cancer Institute | 2013-11-01 |
| Exercise as Treatment of Neck Pain Among Helicopter Pilots and Crew Members (NCT01926262) | University of Southern Denmark | 2013-11-01 |
| Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores (NCT01985321) | Topical Remedy | 2013-11-01 |
| FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer (NCT01896869) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-11-01 |
| Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity. (NCT01890408) | Assistance Publique - Hôpitaux de Paris | 2013-11-01 |
| Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO) (NCT02107365) | ANRS, Emerging Infectious Diseases | 2013-11-01 |
| Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA) (NCT01971281) | NovoCure Ltd. | 2013-11-01 |
| Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis (NCT01603355) | Eric B. Suhler | 2013-11-01 |
| LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma (NCT01820364) | Array BioPharma | 2013-11-01 |
| Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction (NCT01977755) | Zealand Pharma | 2013-11-01 |
| Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients (NCT02491905) | Huons Co., Ltd. | 2013-11-01 |
| MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer (NCT02007148) | International Group of Endovascular Oncology | 2013-11-01 |
| Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized. (NCT02022514) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2013-11-01 |
| Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia (NCT01960413) | Vanderbilt University Medical Center | 2013-11-01 |
| A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT01966549) | Janssen Research & Development, LLC | 2013-11-01 |
| Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy (NCT02935972) | Assiut University | 2013-11-01 |
| Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients (NCT01997944) | Beijing Bio-Fortune Ltd. | 2013-11-01 |
| Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study (NCT01996579) | Queen's University | 2013-11-01 |
| OTO-104 for the Treatment of Meniere's Disease (NCT01412177) | Otonomy, Inc. | 2013-11-01 |
| The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients. (NCT02032095) | Japan Blood Products Organization | 2013-11-01 |
| Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01894477) | Fred Hutchinson Cancer Center | 2013-11-01 |
| Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza (NCT02014649) | Biota Scientific Management Pty Ltd | 2013-11-01 |
| Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease (NCT02002585) | Charles University, Czech Republic | 2013-11-01 |
| Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis (NCT01981551) | National Cancer Institute (NCI) | 2013-10-31 |
| Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair (NCT01920594) | GlaxoSmithKline | 2013-10-31 |
| A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD) (NCT01977573) | GlaxoSmithKline | 2013-10-31 |
| Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide (NCT01946165) | M.D. Anderson Cancer Center | 2013-10-31 |
| Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant. (NCT01952470) | The Alfred | 2013-10-31 |
| Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma (NCT01939899) | Millennium Pharmaceuticals, Inc. | 2013-10-31 |
| Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) (NCT01974687) | Merck Sharp & Dohme LLC | 2013-10-31 |
| Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01989598) | National Cancer Institute (NCI) | 2013-10-30 |
| Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood (NCT02142569) | University of California, Los Angeles | 2013-10-30 |
| Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain (NCT01912612) | University of Michigan Rogel Cancer Center | 2013-10-30 |
| Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic) (NCT02267304) | Institut National de la Santé Et de la Recherche Médicale, France | 2013-10-30 |
| A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) (NCT01891344) | pharmaand GmbH | 2013-10-30 |
| Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer (NCT01787331) | University of California, San Francisco | 2013-10-29 |
| Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma (NCT01881789) | Amgen | 2013-10-28 |
| Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) (NCT01968668) | Bayer | 2013-10-28 |
| Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 (NCT01975818) | Bayer | 2013-10-28 |
| Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01866423) | University of Southern California | 2013-10-25 |
| Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy (NCT01980056) | Weill Medical College of Cornell University | 2013-10-25 |
| Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS). (NCT01835587) | Celgene | 2013-10-25 |
| F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma (NCT02054884) | Philogen S.p.A. | 2013-10-25 |
| T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer (NCT01967823) | National Cancer Institute (NCI) | 2013-10-24 |
| A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors (NCT01928394) | Bristol-Myers Squibb | 2013-10-24 |
| Ultrasound Guided Posterior Sacroiliac Ligament Corticosteroid Injection in Pregnancy-Related Pelvic Girdle Pain (NCT02044991) | Loyola University | 2013-10-24 |
| Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer (NCT01896856) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-10-23 |
| Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension (NCT01915940) | ForSight Vision5, Inc. | 2013-10-23 |
| Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age (NCT01974895) | GlaxoSmithKline | 2013-10-23 |
| Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer (NCT01872260) | Novartis Pharmaceuticals | 2013-10-22 |
| A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas (NCT01837862) | Julie Krystal | 2013-10-22 |
| A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia (NCT01853228) | Janssen Research & Development, LLC | 2013-10-22 |
| Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) (NCT01852110) | Merck Sharp & Dohme LLC | 2013-10-22 |
| Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis (NCT01986920) | Aclaris Therapeutics, Inc. | 2013-10-22 |
| Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma (NCT01967576) | National Cancer Institute (NCI) | 2013-10-19 |
| Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material (NCT01970306) | Memorial Sloan Kettering Cancer Center | 2013-10-18 |
| Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery (NCT02158520) | Academic and Community Cancer Research United | 2013-10-18 |
| Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors (NCT01967537) | National Cancer Institute (NCI) | 2013-10-18 |
| Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma (NCT01833520) | M.D. Anderson Cancer Center | 2013-10-16 |
| Islet Cell Transplant for Type 1 Diabetes (NCT01909245) | City of Hope Medical Center | 2013-10-16 |
| Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (NCT01767129) | Avanir Pharmaceuticals | 2013-10-16 |
| Stannsoporfin With Light Therapy for Newborn Babies With Jaundice (NCT01887327) | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 2013-10-16 |
| Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase (NCT01872442) | Poitiers University Hospital | 2013-10-15 |
| VPD-737 for Treatment of Chronic Pruritus (NCT01951274) | Vyne Therapeutics Inc. | 2013-10-15 |
| CT Antigen TCR-Engineered T Cells for Myeloma (NCT01892293) | Adaptimmune | 2013-10-15 |
| Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT01836029) | Celgene | 2013-10-14 |
| Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant (NCT01927731) | M.D. Anderson Cancer Center | 2013-10-14 |
| A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT01872689) | Hoffmann-La Roche | 2013-10-13 |
| Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb (NCT02012088) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2013-10-11 |
| Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (NCT01523821) | Fred Hutchinson Cancer Center | 2013-10-11 |
| Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) (NCT02000050) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2013-10-11 |
| Hypofractionated Proton Beam Therapy for Localized Prostate Cancer (NCT01950351) | M.D. Anderson Cancer Center | 2013-10-10 |
| MEK162 for Patients With RAS/RAF/MEK Activated Tumors (NCT01885195) | Pfizer | 2013-10-10 |
| Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer (NCT04091178) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-10-10 |
| Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD (NCT01808196) | Children's Hospital Medical Center, Cincinnati | 2013-10-10 |
| Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02014558) | Astellas Pharma Global Development, Inc. | 2013-10-09 |
| Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01962948) | Fox Chase Cancer Center | 2013-10-09 |
| Colon Neoadjuvant FOLFOXIRI Study (NCT01941641) | Chinese University of Hong Kong | 2013-10-09 |
| Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies (NCT01921387) | Fred Hutchinson Cancer Center | 2013-10-09 |
| Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer (NCT01902173) | National Cancer Institute (NCI) | 2013-10-08 |
| Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults (NCT01991587) | Medicago | 2013-10-08 |
| Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study (NCT01973322) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2013-10-08 |
| Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) (NCT01894516) | Lakefront Biotherapeutics NV | 2013-10-08 |
| Pain Management in Children and Young Adults With Sickle Cell Disease (NCT01954927) | St. Jude Children's Research Hospital | 2013-10-07 |
| A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT01797523) | M.D. Anderson Cancer Center | 2013-10-07 |
| Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency (NCT01958281) | Gilead Sciences | 2013-10-07 |
| Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery (NCT01867606) | Mayo Clinic | 2013-10-04 |
| Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia (NCT01862250) | Johns Hopkins University | 2013-10-03 |
| Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder (NCT01939353) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-10-03 |
| Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI. (NCT01848132) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2013-10-03 |
| Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer (NCT01964924) | National Cancer Institute (NCI) | 2013-10-02 |
| High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer (NCT01896271) | University of Texas Southwestern Medical Center | 2013-10-02 |
| Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge (NCT01938352) | Crucell Holland BV | 2013-10-02 |
| Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer (NCT01931046) | Momotaro-Gene Inc. | 2013-10-01 |
| Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma (NCT01968317) | Xiaojun Chen | 2013-10-01 |
| Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases (NCT01818713) | The Netherlands Cancer Institute | 2013-10-01 |
| CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission (NCT01639456) | Masonic Cancer Center, University of Minnesota | 2013-10-01 |